Work

405 POSTER A phase I dose-escalation study of the safety and pharmacokinetics of a XL184, a VEGFR and Met kinase inhibitor, administered orally to subjects with advanced malignancies

Year: 2006

Type: article

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(06)70410-4

Authors: R. Kurzrock, L. Camacho, D. Hong, C. Ng, L. Janisch, M.J. Ratain, R. Salgia

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1990209210

FWCI: 0.27

Cites:

Cited by: 9

Related to: 10